Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015242
Filing Date
2022-08-08
Accepted
2022-08-08 07:16:12
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrr-20220630.htm   iXBRL 10-Q 2943271
2 EX-31.1 tcrr-ex31_1.htm EX-31.1 19705
3 EX-31.2 tcrr-ex31_2.htm EX-31.2 18104
4 EX-32.1 tcrr-ex32_1.htm EX-32.1 15809
5 GRAPHIC img16043007_0.jpg GRAPHIC 35409
  Complete submission text file 0000950170-22-015242.txt   9242078

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrr-20220630.xsd EX-101.SCH 52005
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrr-20220630_def.xml EX-101.DEF 180483
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrr-20220630_cal.xml EX-101.CAL 53949
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrr-20220630_pre.xml EX-101.PRE 326465
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrr-20220630_lab.xml EX-101.LAB 443263
65 EXTRACTED XBRL INSTANCE DOCUMENT tcrr-20220630_htm.xml XML 1604557
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

EIN.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38811 | Film No.: 221142540
SIC: 2836 Biological Products, (No Diagnostic Substances)